quinazolines has been researched along with morphine-6-glucuronide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gu, JK; Hao, M; Jiang, HD; Jim Wang, ZJ; Ju, HX; Li, L; Xu, MC; Yang, ZZ; Yu, LS; Zeng, S | 1 |
1 other study(ies) available for quinazolines and morphine-6-glucuronide
| Article | Year |
|---|---|
Brain-derived neurotrophic factor involved epigenetic repression of UGT2B7 in colorectal carcinoma: A mechanism to alter morphine glucuronidation in tumor.
Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Azepines; Brain-Derived Neurotrophic Factor; Cancer Pain; Cell Line, Tumor; Colorectal Neoplasms; Drug Tolerance; Epigenetic Repression; Female; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Glucuronosyltransferase; Histocompatibility Antigens; Histone-Lysine N-Methyltransferase; Histones; Humans; Immunohistochemistry; Male; Middle Aged; Morphine; Morphine Derivatives; Neoplasm Proteins; Polycomb Repressive Complex 1; Polycomb Repressive Complex 2; Promoter Regions, Genetic; Quinazolines; RNA Interference; RNA, Small Interfering; Transcription Factors; Up-Regulation | 2017 |